Variant report
Variant | esv3386656 |
---|---|
Chromosome Location | chr8:86255600-86257598 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CA1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181705146 | chr8:86255663-86255664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74735542 | chr8:86255674-86255675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561890313 | chr8:86255693-86255694 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567821295 | chr8:86255751-86255752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140416887 | chr8:86255793-86255794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529641385 | chr8:86255812-86255813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58895193 | chr8:86255853-86255854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71522994 | chr8:86255879-86255880 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs545369138 | chr8:86255889-86255890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186698023 | chr8:86255896-86255897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1496530 | chr8:86255898-86255899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs367843344 | chr8:86255923-86255924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563732219 | chr8:86255926-86255927 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190054282 | chr8:86255930-86255931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371246813 | chr8:86255943-86255944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560756757 | chr8:86255985-86255986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529849815 | chr8:86256018-86256019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540207488 | chr8:86256055-86256056 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150337208 | chr8:86256062-86256063 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532040408 | chr8:86256207-86256208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34854684 | chr8:86256209-86256210 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs12544332 | chr8:86256210-86256211 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs372386699 | chr8:86256246-86256247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374600275 | chr8:86256310-86256311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377559609 | chr8:86256311-86256312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56308220 | chr8:86256328-86256329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145009883 | chr8:86256353-86256354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536855468 | chr8:86256375-86256376 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113843712 | chr8:86256384-86256385 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs11780635 | chr8:86256393-86256394 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs535481977 | chr8:86256403-86256404 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs111614058 | chr8:86256405-86256406 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs548263948 | chr8:86256423-86256424 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs554412795 | chr8:86256424-86256425 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs567906614 | chr8:86256450-86256451 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs536845470 | chr8:86256451-86256452 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs547010571 | chr8:86256452-86256453 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs567129405 | chr8:86256453-86256454 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs13273635 | chr8:86256457-86256458 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs372545352 | chr8:86256474-86256475 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs71273930 | chr8:86256480-86256481 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs143069075 | chr8:86256488-86256489 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs572813957 | chr8:86256497-86256498 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs55810560 | chr8:86256501-86256502 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs71522995 | chr8:86256515-86256516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549104342 | chr8:86256516-86256517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533594084 | chr8:86256519-86256520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539994510 | chr8:86256526-86256527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575195503 | chr8:86256530-86256531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562908369 | chr8:86256532-86256533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:86244800-86263600 | Weak transcription | Fetal Intestine Large | intestine |
2 | chr8:86253000-86257200 | Weak transcription | Psoas Muscle | Psoas |
3 | chr8:86254600-86256400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr8:86255000-86255600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
5 | chr8:86255000-86256200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr8:86255400-86256000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
7 | chr8:86255400-86257200 | Weak transcription | HepG2 | liver |
8 | chr8:86255600-86255800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
9 | chr8:86255800-86257200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
10 | chr8:86256000-86256200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
11 | chr8:86256200-86256600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr8:86256400-86257000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
13 | chr8:86256600-86257800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr8:86257000-86257600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
15 | chr8:86257000-86257600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
16 | chr8:86257200-86257600 | Enhancers | Psoas Muscle | Psoas |
17 | chr8:86257200-86257600 | Enhancers | Sigmoid Colon | Sigmoid Colon |
18 | chr8:86257200-86257600 | Bivalent Enhancer | HepG2 | liver |